Erythropoietin (EPO) is a glycoprotein hormone produced naturally in the kidneys, stimulating red blood cell creation. LNP-mediated mRNA drugs utilize lipid nanoparticle (LNP) technology to deliver modified mRNA into cells.
Human EPO plays a role in LNP-mediated mRNA drug discovery by serving as a carrier for mRNA in drug development.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: